InvestSMART

Phosphagenics Limited (ASX: POH) - Announcements

- Current share price for POH : $0.003

ASX company news and announcements for Phosphagenics Limited (POH) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Phosphagenics Limited (POH) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Phosphagenics Limited (POH), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Phosphagenics Limited (POH)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- POH Anti-Cancer Compound GTP-805 Animal Trials Initiated 24 Jan 2006 9:41AM $0.250 $0.003 fallen by 98.80%
- Phase 1b clinical trail results-transdermal morphine gel 18 Jan 2006 9:16AM $0.260 $0.003 fallen by 98.85%
- Appendix 3B - A$11.25M Equity Placement 14 Nov 2005 7:31PM $0.250 $0.003 fallen by 98.80%
- Phosphagenics - ALZA Corporation - Development Agreement 7 Nov 2005 9:13AM $0.265 $0.003 fallen by 98.87%
- Second Study - Phospha E 21 Oct 2005 10:02AM $0.250 $0.003 fallen by 98.80%
- Transdermal delivery of insulin 20 Sep 2005 8:30AM $0.270 $0.003 fallen by 98.89%
- Response to ASX Query - Share Price 14 Sep 2005 9:21AM $0.275 $0.003 fallen by 98.91%
- Phosphagenics - Appendix 4D Report June 2005 30 Aug 2005 8:02PM $0.255 $0.003 fallen by 98.82%
- Successfully delivers morphine through human skin 19 Apr 2005 9:44AM $0.320 $0.003 fallen by 99.06%
- Completion of Animal Trial for New Drug APA-01 15 Apr 2005 8:30AM $0.330 $0.003 fallen by 99.09%
- AusIndustry R & D START Grant 15 Dec 2004 7:30PM $0.320 $0.003 fallen by 99.06%
- Major global pharmaceutical co endorses POH's science 23 Nov 2004 9:39AM $0.380 $0.003 fallen by 99.21%
- Completes Further UK Placement 3 Nov 2004 10:23AM $0.275 $0.003 fallen by 98.91%
- Meets with US FDA to discuss Devt Prog for new morphine prod 8 Oct 2004 10:27AM $0.195 $0.003 fallen by 98.46%
- Patented Vitamin E on sale throughout US 10 Aug 2004 11:20AM $0.200 $0.003 fallen by 98.50%
- Trials in Heart Treatment 5 May 2004 2:22PM $0.200 $0.003 fallen by 98.50%
- Trials in Heart Treatment 5 May 2004 2:22PM $0.200 $0.003 fallen by 98.50%

326 - 342 of 342 results

Page 14 of 14

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.